4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc.

FDMT
4D Molecular Therapeutics, Inc.US flagNASDAQ Global Select
11.38
USD
+0.29
- -
594.64MMarket Cap

Income Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
6
14
7
14
18
3
21
- -
85
+ Sales & Services Revenue
6
14
7
14
18
3
21
- -
85
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
-6
-14
-7
-14
-18
-3
-21
- -
-85
- Operating Expenses
17
25
53
70
89
113
134
188
245
+ Selling, General & Admin
3
6
14
17
28
33
36
47
49
+ Research & Development
14
18
39
53
61
80
97
141
196
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-11
-10
-46
-57
-71
-110
-113
-188
-160
- Non-Operating (Income) Loss
- -
-1
4
- -
- -
-3
-12
-27
-19
+ Interest Expense, Net
- -
-1
-2
- -
- -
-3
-12
-27
-19
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
1
2
- -
- -
3
12
27
19
+ Other Non-Op (Income) Loss
- -
- -
5
- -
- -
- -
- -
- -
- -
Pretax Income
-11
-10
-49
-57
-71
-107
-101
-161
-140
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-11
-10
-49
-57
-71
-107
-101
-161
-140
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-11
-10
-49
-57
-71
-107
-101
-161
-140
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-11
-10
-49
-57
-71
-107
-101
-161
-140
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-11
-10
-49
-57
-71
-107
-101
-161
-140
EBIT
-11
-10
-46
-57
-71
-110
-113
-188
-160
EBITDA
-11
-10
-45
-55
-68
-106
-107
-181
-152
EBITDA Margin (%)
-183.87
-68.66
-638.75
-405.68
-378.72
-3,392.52
-516.9
-489,556.76
-178.29
EBITA
-11
-10
-46
-57
-71
-110
-113
-188
-160
Gross Margin (%)
100
100
100
100
100
100
100
100
100
Operating Margin (%)
-194.68
-73.6
-653.12
-416.28
-395.46
-3,516.52
-544.65
-507,678.38
-187.24
Profit Margin (%)
-193.83
-67.59
-705.78
-416.49
-395.37
-3,435.41
-486.59
-434,778.38
-164.43
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
1
1
1
1
3
4
6
7
8
Basic Weighted Avg Shares
15
13
15
6
28
32
39
54
58
Basic EPS, GAAP
-0.76
-0.76
-3.32
-8.82
-2.57
-3.32
-2.58
-2.98
-2.42
Basic EPS from Cont Ops
-0.76
-0.76
-3.32
-8.82
-2.57
-3.32
-2.58
-2.98
-2.42
Diluted Weighted Avg Shares
15
13
15
6
28
32
39
54
58
Diluted EPS, GAAP
-0.76
-0.76
-3.32
-8.82
-2.57
-3.32
-2.58
-2.98
-2.42
Diluted EPS from Cont Ops
-0.76
-0.76
-3.32
-8.82
-2.57
-3.32
-2.58
-2.98
-2.42

Balance Sheet (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
24
94
53
283
256
221
297
435
413
+ Cash, Cash Equivalents & STI
24
92
50
277
248
214
288
425
403
+ Cash & Cash Equivalents
24
92
50
277
153
52
249
149
60
+ ST Investments
- -
- -
- -
- -
95
161
39
276
342
+ Accounts & Notes Receiv
- -
1
1
1
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
1
1
1
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
2
4
8
7
8
10
10
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
3
3
6
6
97
41
43
125
154
+ Property, Plant & Equip, Net
3
2
5
5
29
35
32
41
33
+ Property, Plant & Equip
4
4
8
9
34
43
44
57
54
- Accumulated Depreciation
1
2
3
4
5
8
12
17
21
+ LT Investments & Receivables
- -
- -
- -
- -
68
5
11
81
111
+ LT Investments
- -
- -
- -
- -
68
5
11
81
111
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
1
1
1
1
4
9
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
1
1
1
1
4
9
Total Assets
27
97
58
288
353
262
340
560
567
+ Payables & Accruals
2
3
7
10
13
12
16
23
38
+ Accounts Payable
- -
1
2
2
5
3
4
4
11
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
5
8
8
9
12
19
27
+ ST Debt
- -
- -
- -
- -
1
3
3
6
6
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
1
3
3
6
6
+ Other ST Liabilities
4
5
6
7
3
1
- -
- -
- -
+ Deferred Revenue
4
5
6
7
3
1
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
6
8
13
17
16
16
19
29
44
+ LT Debt
- -
- -
- -
- -
15
13
12
19
16
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
15
13
12
19
16
+ Other LT Liabilities
41
117
118
15
3
1
2
2
1
+ Accrued Liabilities
22
13
14
14
2
1
1
1
1
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
19
103
105
1
- -
- -
1
1
- -
Total Noncurrent Liabilities
41
117
118
15
18
15
13
21
17
Total Liabilities
47
125
131
32
34
31
32
50
61
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
2
6
392
527
547
723
1,087
1,221
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
2
6
392
527
547
723
1,087
1,221
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-20
-30
-79
-136
-207
-314
-415
-576
-716
+ Other Equity
- -
- -
- -
- -
- -
-1
- -
- -
1
Equity Before Minority Interest
-20
-28
-73
256
319
231
308
511
506
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-20
-28
-73
256
319
231
308
511
506
Total Liabilities & Equity
27
97
58
288
353
262
340
560
567
Shares Outstanding
22
22
22
27
32
33
43
46
58
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
16
16
15
25
21
Net Debt
-24
-92
-50
-277
-153
-52
-249
-149
-60
Net Debt to Equity
121.75
332.62
68.04
-107.93
-47.95
-22.63
-80.92
-29.25
-11.91
Tangible Common Equity Ratio
-71.71
-28.45
-125.3
88.92
90.27
88.35
90.57
91.12
89.23
Current Ratio
4.15
11.68
4.05
16.88
15.69
14.02
15.65
14.92
9.39
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-11
-10
-49
-57
-71
-107
-101
-161
-140
+ Depreciation & Amortization
1
1
1
1
3
4
6
7
8
+ Non-Cash Items
- -
1
11
5
15
18
19
19
17
+ Stock-Based Compensation
- -
1
4
5
14
17
20
26
22
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
3
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
5
- -
1
1
-1
-7
-5
+ Chg in Non-Cash Work Cap
19
-9
- -
-1
-16
-1
1
1
6
+ (Inc) Dec in Accts Receiv
- -
-1
- -
-1
1
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-1
-3
-4
1
-1
-2
- -
+ Inc (Dec) in Accts Payable
- -
2
4
2
3
1
4
7
15
+ Inc (Dec) in Other
19
-9
-4
- -
-16
-3
-2
-5
-8
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
8
-16
-37
-51
-69
-87
-76
-135
-109
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
- -
-3
-1
-9
-12
-3
-4
-1
+ Acq of Fixed Prod Assets
-1
- -
-3
-1
-9
-12
-3
-4
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
-2
206
114
- -
148
331
111
+ Increase in Capital Stock
- -
- -
- -
206
114
- -
148
331
111
+ Decrease in Capital Stock
- -
- -
-2
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
8
- -
- -
- -
-164
-6
118
-299
-92
+ Dec in LT Investment
8
- -
- -
- -
5
148
173
169
350
+ Inc in LT Investment
- -
- -
- -
- -
-169
-153
-55
-468
-443
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
8
- -
-3
-1
-173
-17
116
-302
-93
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
84
- -
73
4
3
8
6
2
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
85
-2
279
118
3
157
337
113
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
16
68
-42
227
-124
-101
197
-100
-89
EBITDA
-11
-10
-45
-55
-68
-106
-107
-181
-152
EBITDA Margin (%)
-183.87
-68.66
-638.75
-405.68
-378.72
-3,392.52
-516.9
-489,556.76
-178.29
Free Cash Flow
8
-17
-40
-52
-78
-98
-79
-138
-110
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-17
-40
-52
-78
-98
-79
-138
-110
Free Cash Flow per Basic Share
0.52
-1.33
-2.69
-8.07
-2.82
-3.04
-2.01
-2.57
-1.89
Price/Free Cash Flow
- -
- -
- -
-5.34
-10.14
-9.56
-10.86
-2.3
-4
Cash Flow to Net Income
-0.73
1.7
0.74
0.9
0.97
0.81
0.75
0.84
0.78
Capital Expenditures
-1
- -
-3
-1
-9
-12
-3
-4
-1